Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,230 total articles
Edward Oliver Gillespie, CEO and director of Abundia Global Impact Group, Inc. (AGIG), recently conducted multiple open market purchases of the company's common stock between May 12 and May 14, 2026. These transactions represent a notable acquisition by an insider at a time when the stock was trading near its 52-week low and following a significant…
Planet Fitness CEO, Colleen Keating, recently purchased a significant block of the company’s common stock. This transaction occurred against a backdrop of strong Q1 2026 financial results for Planet Fitness, Inc., which notably surpassed analyst expectations for both earnings per share and revenue. Despite these positive financial metrics, analysts…
David Cordani, Chairman and CEO of The Cigna Group (CI), executed substantial stock sales totaling approximately $59.1 million while simultaneously acquiring shares worth around $36.2 million on May 12 and 13, 2026. These transactions were all conducted under a pre-arranged Rule 10b5-1 trading plan established earlier in the year.The reported activ…
Devesh Agarwal, Chief Operating Officer at Bandwidth Inc. (NASDAQ:BAND), sold a total value of over $1 million worth of company shares across two days in May 2026. This insider activity occurs against a backdrop of strong recent financial reporting for the first quarter of 2026 and positive analyst developments, including a raised price target.
A director at Universal Insurance Holdings, Inc. sold a total of $295,433 worth of company stock over two days in May 2026. This activity occurred against the backdrop of the company's first-quarter 2026 earnings report. While UVE reported an Earnings Per Share (EPS) of $2.00, significantly beating estimates of $1.47, revenue came in at $393.57 mil…
Chief Human Resources Officer Kaitlin Haggerty recently reported the sale of company common stock totaling $262,124 for Capital One Financial Corp. The transaction spanned May 12 and May 13, 2026. This activity occurred alongside other recent corporate disclosures, including Q1 2026 earnings which saw adjusted EPS falling below forecasts, coupled w…
Tapestry's Chief Executive Officer, Joanne C. Crevoiserat, recently sold a substantial amount of company common stock. This activity occurred against a backdrop of strong financial reporting for the third quarter of fiscal year 2026. While the company reported revenues and earnings significantly exceeding expectations, market reaction suggested cau…
DexCom director Bridgette P. Heller sold a block of common stock on May 12, 2026, valued at $60,730. This sale occurred while the stock was trading near its 52-week low. However, recent operational data and institutional activity point to strong underlying fundamentals for DexCom, including robust Q1 revenue growth and multiple price target increas…
Capital One's General Counsel reported a sale of company stock, occurring while the firm released Q1 2026 results that missed analyst expectations. The report also details recent market data concerning consumer spending trends and adjustments to future growth forecasts for US consumers, alongside the announcement of a quarterly dividend.
Eastman Kodak Co. director Philippe D. Katz purchased $20,600 worth of common stock on May 13, 2026. This transaction occurred despite a recent decline in the stock price over the past week, while the company reported Q1 2026 earnings showing a revenue increase to $265 million. The report details Katz's substantial holdings and outlines current fin…
Gregory S. Daily, CEO of i3 Verticals, Inc., recently purchased a significant block of the company's common stock. This transaction occurs while the stock is trading near its 52-week low following a decline over the last week. While recent earnings for fiscal Q2 2026 exceeded expectations, several major financial institutions have simultaneously lo…
Vice President Stefan Demmerle of BorgWarner Inc. executed a sale of company stock totaling $325,000 on May 13, 2026. This insider activity occurs while the company's shares are trading near their annual high of $70.08 and following recent positive financial disclosures for Q1 2026, where BorgWarner reported earnings per share (EPS) of $1.24 and re…
The recent actions of BorgWarner Inc.'s President and CEO, Joseph F. Fadool, including a significant stock sale, are being analyzed alongside the company's robust first quarter performance. The CEO sold shares valued at approximately $1.95 million on May 13, 2026. Despite this insider activity, BorgWarner reported strong Q1 earnings per share of $1…
Charles Alan Williams, Chairman and CEO of Northpointe Bancshares Inc., recently acquired a significant block of the company's common stock. This transaction occurred while the firm reported strong financial results for the first quarter of 2026, indicating robust profitability and maintained asset quality despite changes in net interest income.
Michael N. Intrator, the Chief Executive Officer and President of CoreWeave, Inc., recently executed a substantial sale of company stock valued at over $32 million. This transaction was conducted under a prearranged Rule 10b5-1 trading plan. The timing of this selling activity is noted against a backdrop of mixed performance for the company's share…
The recent transactions involving Cytokinetics, Inc. (NASDAQ:CYTK) reveal a mix of insider activity and significant corporate financial maneuvers. CEO Robert I. Blum sold a notable block of shares on May 14, 2026, while the company simultaneously completed a large stock offering and announced another planned offering. These activities are occurring…
Martin Wilson, General Counsel of Rocket Pharmaceuticals, Inc., sold shares of common stock in a transaction totaling $12,119. This activity occurred against a backdrop of major corporate developments for ROCKET PHARMACEUTICALS, INC., including the successful sale of a Rare Pediatric Disease Priority Review Voucher and positive adjustments to analy…
The recent sale of shares by Michelle Moosally, Chief Legal Officer at Citizens Financial Group Inc./RI (CFG), has drawn attention amidst a backdrop of strong corporate performance. The transaction occurred shortly after the company reported first-quarter 2026 earnings that surpassed market expectations, prompting several major financial institutio…
John Militello, a senior executive at ROCKET PHARMACEUTICALS, INC. (NASDAQ:RCKT), sold 855 shares totaling $3,083 on May 13, 2026. This transaction was specifically utilized to cover tax withholding requirements stemming from the vesting of restricted stock units (RSUs). Despite the sale, the company continues to generate significant financial news…
The reported sale of common stock by Gaurav Shah, CEO of Rocket Pharmaceuticals, Inc., occurred against a backdrop of significant corporate developments. These include the company selling its Rare Pediatric Disease Priority Review Voucher for $180 million and subsequent positive reactions from analysts who have adjusted price targets upward. The an…
Affirm Holdings director, Noel Watson, recently sold a block of company shares. This transaction occurs amidst strong analyst coverage citing aggressive Gross Merchandise Volume (GMV) goals and strategic integrations with major platforms like Google Search and the Gemini app. The analysis notes both the recent insider selling and the consistent pos…
Director Alan Semple sold a significant block of shares in Cactus, Inc. (NASDAQ:WHD) totaling $577,863 on May 12, 2026. This transaction occurred against a backdrop of positive corporate news for the company, which reported Q1 2026 earnings that surpassed market forecasts. Furthermore, Tana Utley was appointed to the board of directors, bringing de…
Twist Bioscience Corp. director Jan Johannessen recently sold a significant amount of company common stock, while the company also reported mixed financial results for its second quarter of fiscal year 2026. While Q2 revenues saw a substantial increase compared to prior years, the earnings per share (EPS) missed analyst expectations, leading to var…
Matthijs Glastra, the Chief Executive Officer and Director at Novanta Inc., executed a sale of corporate shares totaling $1.12 million on May 12, 2026. This transaction occurred while the stock was trading near its 52-week high. Separately, Novanta reported mixed first-quarter 2026 financial results: earnings per share (EPS) missed estimates but re…
Director Michael Y. McGovern sold 12,000 shares of Cactus, Inc.'s Class A Common Stock on May 12, 2026, for a total value of $678,840. This transaction occurred despite the stock's recent strong performance and following a quarter where the company reported robust financial results. Furthermore, corporate updates included the election of Tana Utley…
